Page last updated: 2024-11-05

zonisamide and Brain Injuries, Traumatic

zonisamide has been researched along with Brain Injuries, Traumatic in 2 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Brain Injuries, Traumatic: A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.

Research Excerpts

ExcerptRelevanceReference
"The levetiracetam dosage was increased (150 mg/kg [68 mg/lb], PO, q 8 h), and zonisamide (20 mg/kg [9."1.56Diagnosis and long-term management of post-traumatic seizures in a white-crowned pionus ( ( Beaufrère, H; Brouwer, E; James, F; Kabakchiev, C; Laniesse, D; Zur Linden, A, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Kumar, S3
Singh, G3
Kabakchiev, C1
Laniesse, D1
James, F1
Zur Linden, A1
Brouwer, E1
Beaufrère, H1

Other Studies

2 other studies available for zonisamide and Brain Injuries, Traumatic

ArticleYear
Pharmacological potential of zonisamide and Nigella sativa per se and combination in high-impact trauma device-induced traumatic brain injury in Drosophila melanogaster.
    Fundamental & clinical pharmacology, 2023, Volume: 37, Issue:3

    Topics: Animals; Brain Injuries, Traumatic; Drosophila melanogaster; Drosophila Proteins; Nigella sativa; Ox

2023
Pharmacological potential of zonisamide and Nigella sativa per se and combination in high-impact trauma device-induced traumatic brain injury in Drosophila melanogaster.
    Fundamental & clinical pharmacology, 2023, Volume: 37, Issue:3

    Topics: Animals; Brain Injuries, Traumatic; Drosophila melanogaster; Drosophila Proteins; Nigella sativa; Ox

2023
Pharmacological potential of zonisamide and Nigella sativa per se and combination in high-impact trauma device-induced traumatic brain injury in Drosophila melanogaster.
    Fundamental & clinical pharmacology, 2023, Volume: 37, Issue:3

    Topics: Animals; Brain Injuries, Traumatic; Drosophila melanogaster; Drosophila Proteins; Nigella sativa; Ox

2023
Pharmacological potential of zonisamide and Nigella sativa per se and combination in high-impact trauma device-induced traumatic brain injury in Drosophila melanogaster.
    Fundamental & clinical pharmacology, 2023, Volume: 37, Issue:3

    Topics: Animals; Brain Injuries, Traumatic; Drosophila melanogaster; Drosophila Proteins; Nigella sativa; Ox

2023
Pharmacological potential of zonisamide and Nigella sativa per se and combination in high-impact trauma device-induced traumatic brain injury in Drosophila melanogaster.
    Fundamental & clinical pharmacology, 2023, Volume: 37, Issue:3

    Topics: Animals; Brain Injuries, Traumatic; Drosophila melanogaster; Drosophila Proteins; Nigella sativa; Ox

2023
Pharmacological potential of zonisamide and Nigella sativa per se and combination in high-impact trauma device-induced traumatic brain injury in Drosophila melanogaster.
    Fundamental & clinical pharmacology, 2023, Volume: 37, Issue:3

    Topics: Animals; Brain Injuries, Traumatic; Drosophila melanogaster; Drosophila Proteins; Nigella sativa; Ox

2023
Pharmacological potential of zonisamide and Nigella sativa per se and combination in high-impact trauma device-induced traumatic brain injury in Drosophila melanogaster.
    Fundamental & clinical pharmacology, 2023, Volume: 37, Issue:3

    Topics: Animals; Brain Injuries, Traumatic; Drosophila melanogaster; Drosophila Proteins; Nigella sativa; Ox

2023
Pharmacological potential of zonisamide and Nigella sativa per se and combination in high-impact trauma device-induced traumatic brain injury in Drosophila melanogaster.
    Fundamental & clinical pharmacology, 2023, Volume: 37, Issue:3

    Topics: Animals; Brain Injuries, Traumatic; Drosophila melanogaster; Drosophila Proteins; Nigella sativa; Ox

2023
Pharmacological potential of zonisamide and Nigella sativa per se and combination in high-impact trauma device-induced traumatic brain injury in Drosophila melanogaster.
    Fundamental & clinical pharmacology, 2023, Volume: 37, Issue:3

    Topics: Animals; Brain Injuries, Traumatic; Drosophila melanogaster; Drosophila Proteins; Nigella sativa; Ox

2023
Diagnosis and long-term management of post-traumatic seizures in a white-crowned pionus (
    Journal of the American Veterinary Medical Association, 2020, May-15, Volume: 256, Issue:10

    Topics: Animals; Anticonvulsants; Brain Injuries, Traumatic; Female; Levetiracetam; Parrots; Seizures; Zonis

2020